Montefiore Performs 300th Heart Transplant
Celebrating 60 Years of Innovative Heart Surgery, Montefiore is Rated Best in New York City for One-Year Patient Survival Rates in Heart Transplant
Montefiore Medical Center transplanted its 300th heart, marking a major milestone since the heart transplant program’s inception in 1999. In addition to the best one-year patient survival rates for both pediatric and adult heart transplants in New York City, Montefiore also claims the best three-year patient survival rates for adult transplants in New York City.
“For nearly 20 years, Montefiore’s heart transplant program has continued to grow and excel, achieving highly competitive patient survival rates while also sustaining our commitment to access to healthcare for all,” said Robert E. Michler, MD, Professor and Chairman of Cardiothoracic & Vascular Surgery, Professor and Chairman of the Department of Surgery, Samuel I. Belkin Endowed Chair, Montefiore Health System and Albert Einstein College of Medicine. “We are also proud of our leadership role in the field of heart surgery as evidenced by our work as principal investigators in major national clinical trials.”
“Heart failure is a global epidemic affecting more than six million patients in the United States alone,” said Ulrich Jorde, MD, Section Head, Heart Failure, Cardiac Transplantation and Mechanical Circulatory Support, Vice Chief, Division of Cardiology, Professor of Medicine, Montefiore Health System and Albert Einstein College of Medicine.
Montefiore’s excellence in treating heart failure, as evidenced by the 300th heart transplant, has a long and accomplished history. Our first adult heart transplant was performed in 2001, followed by our first pediatric transplant in 2009. The longest living Montefiore heart transplant patient to date recently celebrated his 15th “birthday,” the anniversary of his transplant surgery.
With the 300th heart transplant, Montefiore performed its second bloodless heart transplant, using no blood transfusions: a major innovation in transplant care. Montefiore performed its first bloodless heart transplant in October 2014. “Because our program continues to offer patients of all backgrounds the opportunity to live a healthier life, our annual volume of heart transplants continues to grow,” said Daniel Goldstein, MD, Professor and Vice Chairman of the Department of Cardiothoracic Surgery, Montefiore Einstein Center for Heart & Vascular Care. “We are committed to using our expertise to turn lives around and give people hope. Using bloodless surgery is just one of the techniques we use to meet the needs of our culturally diverse population.”
This year, Montefiore is celebrating 60 years of performing heart surgery. The Center’s first open-heart surgery in 1957 was the beginning of a long history of clinical excellence including developing and using the world’s first transvenous pacemaker system in 1958, and performing the first coronary artery bypass operation in 1960. Montefiore Einstein Center for Heart & Vascular Care has since become a nationally recognized destination for superior care.